-
2621
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression
Published 2025-01-01“…Background The E3 ubiquitin ligase murine double minute 2 (MDM2) binds the p53 transcriptional activation domain and acts as a potent inhibitor of TP53 pathway, one of the three most crucial oncogenic pathways in urothelial carcinoma (UC). …”
Get full text
Article -
2622
Comparative effective dose of ciprofol and propofol in suppressing cardiovascular responses to tracheal intubation
Published 2025-01-01“…Abstract Ciprofol, a novel γ-aminobutyric acid receptor agonist, outperforms propofol with minimal cardiovascular effects, higher potency, reduced injection pain, and a broader safety margin. …”
Get full text
Article -
2623
Copper homeostasis and neurodegenerative diseases
Published 2025-11-01“…However, the exact mechanisms underlying these processes are not known. Copper is a potent oxidant that increases reactive oxygen species production and promotes oxidative stress. …”
Get full text
Article -
2624
Mechanism of melanoma suppression by Prosopis juliflora derived alkaloids: Apoptosis induction and signaling pathway inhibition
Published 2025-02-01“…Results: PJLME-AF demonstrated potent anti-proliferative, anti-migratory and anti-invasive effects on melanoma cells. …”
Get full text
Article -
2625
Serum vascular endothelial growth factor levels as a marker of skin thickening, digital ischemia, and interstitial lung disease in systemic sclerosis
Published 2018-01-01“…Background: Vascular injury is the initial event in the pathogenesis of systemic sclerosis (SSc) and potent proangiogenic mediators such as vascular endothelial growth factor (VEGF) are overexpressed in the skin and circulation of patients with SSc. …”
Get full text
Article -
2626
New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
Published 2024-07-01“…Introduction: Botulinum neurotoxins (BoNTs) cause botulism and are the most potent natural toxins known. Immunotherapy with neutralizing monoclonal antibodies (MAbs) is considered to be the most effective immediate response to BoNT exposure. …”
Get full text
Article -
2627
Optimization of the Antibacterial Activity of a Three-Component Essential Oil Mixture from Moroccan <i>Thymus satureioides</i>, <i>Lavandula angustifolia</i>, and <i>Origanum major...
Published 2025-01-01“…Results: The optimized essential oil mixtures demonstrated potent antibacterial activity, with MIC values of 0.097% (<i>v</i>/<i>v</i>) for <i>E. coli</i>, 0.058% (<i>v</i>/<i>v</i>) for <i>S. aureus</i>, and 0.250% (<i>v</i>/<i>v</i>) for <i>P. aeruginosa</i>. …”
Get full text
Article -
2628
Nanotechnology-based herbal medicine: Preparation, synthesis, and applications in food and medicine
Published 2025-03-01“…Nanotechnology and herbal medicine join forces and form a potent medical and nutritional solution to various diseases, food production, and conservation. …”
Get full text
Article -
2629
Intraoperative Analgesia with Magnesium Sulfate versus Remifentanil Guided by Plethysmographic Stress Index in Post-Bariatric Dermolipectomy: A Randomized Study
Published 2022-01-01“…The evaluation of the antinociceptive potency of drugs and doses indirectly, through hemodynamic oscillations has been questioned. …”
Get full text
Article -
2630
Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics f...
Published 2025-01-01“…In vitro studies evaluated the efficacy, safety, and potency of sEV; animal studies confirmed their effectiveness and safety. …”
Get full text
Article -
2631
How Uremic Toxins Alter Atorvastatin Disposition: Molecular Mechanisms of Inhibition of the Enzyme CYP3A4
Published 2025-01-01“…Results: IS and HA inhibited the ATV metabolism to varying degrees, wherein IS was the most potent inhibitor, producing > 50% inhibition. Meanwhile, the protein expression of CYP3A4 was downregulated after incubation with US, IS, and HA (p < 0.01). …”
Get full text
Article -
2632
SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate
Published 2024-12-01“…Overall, our data suggest that SPA14 is a viable, easy-to-manufacture, potent novel adjuvant system that could be broadly applicable as a ready-to-mix adjuvant in the form of a long-term stable liquid formulation.…”
Get full text
Article -
2633
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Published 2025-01-01“…Simultaneous overexpression of the three proteins was associated with significantly reduced survival in resected PDAC patients. CM272 exhibited potent antiproliferative activity in PDAC cell lines, inducing apoptosis and altering key metabolic and cell cycle-related genes. …”
Get full text
Article -
2634
Anti-obesity effects of Erythrina abyssinica stem bark extract in flies exposed to a high fat diet
Published 2023“…Background: An in vitro assay on Sigmoidin A from Erythrina abyssinica stem bark revealed its potency to inhibit pancreatic lipase. However, studies indicate activity of extract bioactive compounds in combination far exceed the favorable effects of each individual compound due to synergy and additive effects. …”
Get full text
Article -
2635
Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation
Published 2025-01-01“…Repeated administration resulted in sustained production of bispecific antibodies with different exposure cycles and potent antitumor activity with a favorable safety profile.ConclusionsThese results highlight the potential of combining two mRNA-encoded bispecific antibodies with different mechanisms of action and programmable half-life for cancer immunotherapy.…”
Get full text
Article -
2636
The potential synergistic effect of combining doxorubicin with vorinostat in urothelial carcinoma therapy
Published 2025-01-01“…Vorinostat is an anticancer drug used to treat cutaneous T-cell lymphoma, and it demonstrates potent combination effects in various anticancer treatments. …”
Get full text
Article -
2637
Melittin ameliorates schistosomiasis-induced liver fibrosis by suppressing signal transducer and activator of transcription 3 and nuclear factor kappa B
Published 2024-12-01“…Results S. mansoni-infected mice showed significant (P<0.05) increases in the pro-inflammatory mediators and upregulate expression of STAT3, and NF-κB compared with the healthy group. MEL exhibited potent anti-inflammatory effects, as evidenced by significant (P<0.05) inhibition of the elevated pro-inflammatory cytokines, including TNF-α and IL-17, as well as immunoglobulin E levels and hepatic GI, while the anti-inflammatory IL-10 was significantly (P<0.05) increased. …”
Get full text
Article -
2638
Simple approach to thieno[3,2-d]pyrimidines as new scaffolds of antimicrobial activities
Published 2016-09-01“…Compounds 2c, 8b,c, 9b and 10b were the most potent ones against both Gram-negative and Gram-positive bacteria. …”
Get full text
Article -
2639
Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis.
Published 2024-01-01“…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC50 values of 2.7 and 3.3 μM, respectively. …”
Get full text
Article -
2640
Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11
Published 2025-01-01“…IntroductionBryostatin-1, a potent agonist of the protein kinase C, has been studied for HIV and cancer therapies. …”
Get full text
Article